Test ID ADALP Adalimumab Quantitative with Antibody, Serum
Ordering Guidance
If there is a known justification for performing both quantitation and antibody levels, this is the correct test to order. If there is not a known reason to perform the antibody levels component, consider ADALX / Adalimumab Quantitative with Reflex to Antibody, Serum. ADALX testing begins with adalimumab quantitation and only performs testing for antibodies when the quantitation results are 8.0 mcg/mL or less.
Specimen Required
Patient Preparation: For 12 hours before specimen collection, patient should not take multivitamins or dietary supplements (eg, hair, skin, and nail supplements) containing biotin (vitamin B7).
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 1.0 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial
Useful For
Therapeutic drug monitoring of adalimumab concentration and antibody levels
Highlights
Adalimumab (brand names Amjevita and Humira) is a fully human therapeutic monoclonal antibody targeting tumor necrosis factor alpha, a proinflammatory cytokine that is upregulated in several autoimmune inflammatory states.
Testing for adalimumab concentration and the presence of anti-adalimumab antibodies is helpful to adjust therapeutic strategies for patients starting therapy (proactive monitoring) and dosing or treatment strategy when partial response or loss of response to therapy is observed, manifested as recurrence of symptoms.
Profile Information
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
QNADL | Adalimumab QN, S | Yes, (ADALX) | Yes |
ABADL | Adalimumab Ab, S | No | Yes |
INTAD | Adalimumab Interpretation | No | Yes |
Testing Algorithm
For more information see Ulcerative Colitis and Crohn Disease Therapeutic Drug Monitoring Algorithm.
Method Name
Enzyme Linked Immunosorbent Assay (ELISA)
Reporting Name
Adalimumab QN with Antibodies, SSpecimen Type
SerumSpecimen Minimum Volume
0.7 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 28 days | |
Frozen | 28 days |
Reference Values
ADALIMUMAB QUANTITATIVE:
Limit of quantitation is 0.8 mcg/mL. Optimal therapeutic ranges are disease specific.
ADALIMUMAB ANTIBODY:
<14.0 AU/mL
Day(s) Performed
Monday, Wednesday, Friday
Report Available
3 to 6 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
80145
83520
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
ADALP | Adalimumab QN with Antibodies, S | 99781-7 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
QNADL | Adalimumab QN, S | 86894-3 |
ABADL | Adalimumab Ab, S | 90779-0 |
INTAD | Adalimumab Interpretation | 77202-0 |
NY State Approved
YesForms
If not ordering electronically, complete, print, and send a Gastroenterology and Hepatology Test Request (T728) with the specimen.